In Latvia, this year, treatment options for men diagnosed with prostate or prostate cancer have improved significantly. As a result, it is possible to extend the life expectancy of those who have already retired the tumor unfortunately. "Healthy young people can not imagine how important it is for men to find themselves in such a situation," said Peter Vagnov, an urologist at the Clinical Hospital of Clinical University Hospital, University Hospital of Straddines.
Not all men manage to get rid of prostate cancer, but in many cases they can live with it for a long time because cancer today is a chronic disease. In addition, since the beginning of the year, state-funded treatment is available at all stages of prostate cancer. There are also development treatments that allow you to stay longer during and after treatment and provide better quality of life than before. Data from the Centers for Disease Control and Prevention (SPCC) show that of 8665 prostate cancer patients registered at the end of 2017, 4,133 records were reported for more than 5 years. If prostate cancer is identified, the urine should be in contact with all of life. It is important to continue regular monitoring of prostate specific antigen (PSA) and to monitor symptoms of progression that may be related to urinary tract problems, erectile dysfunction, blood in urine or semen, low back pain, or upper thighs, as directed by the doctor.
"This year, a lot of work has been done on the health of men in Latvia: the availability of urologists has improved, new opportunities for diagnosis, treatment and observation are offered to men affected by prostate cancer, thus increasing expectations for positive outcomes," he says.
According to the doctor, men suspected of having prostate cancer using the green corridor, with a referral from a family doctor, are available within 10 days. "For those we find malignant tumors, the latest non-invasive treatment methods are available, allowing them to return fully to their daily lives within a few weeks, and after a long time, to restore their strength. , Which can only be done if the man regularly performs the PSA test and goes to the doctor.Thanks Many to the government for approving a number of projects to purchase the latest hardware in urology this year, as well as a national drug return drug that included a new drug to treat prostate cancer in the latest stages of metastatic cancer. Life expectancy of patients, "says F. Vaganov.
What should be known to Latvian men
For almost 20 years, prostate cancer in the world is the most common malignant tumor in men.
• In Latvia, this is the second most common type of cancer. (Data from the National Health Service (NSA)
• In 2016, 1286 new cases of prostate cancer were diagnosed. (SPCC data)
• The number of unique and primary malignant tumors of the prostate in the first eight months of 2018 was 4059 (of which 814 were first). (NVD data)
• In Europe, prostate cancer is about 3 million men, half of whom have lived for five years or more since diagnosis was diagnosed. If an early tumor is detected, it can be dispose of, and a possible remission without recovery from disease for 20 to 30 years or more.
• Even if there are no complaints (prostate cancer in the early stages may not have any symptoms), routine prostate tests should be performed about 50 years of age. From the age of 50, with a GP launcher every two years, the PSA test is paid by the state.
Prostate cancer affects young men. If every person in the family had it, the tests should be done at the beginning of the urine and you should go from the age of 40-45 years.
Prostate cancer can be treated at all stages of the disease. Not only the support and encouragement of medics, but also those around them, is very important.